Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Decadron (dexamethasone) / Merck (MSD)

NCT00871910: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

	P1 data
	Jun 2011 - Jun 2011: P1 data

Completed

SCH 727965, Aprepitant, Emend, Ondansetron, Zofran, Dexamethasone, Decadron

Merck Sharp & Dohme LLC

Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma

02/10

NCT01331590: Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

Completed

G-CSF, Filgrastim, Neupogen, Granulocyte Colony-Stimulating Factor, Recombinant Methionyl Human G-CSF, Ifosfamide, Ifex, Isophosphamide, Etoposide, Etopophos, VP-16, Dexamethasone, Decadron, Mesna, Mesnex

Washington University School of Medicine

Precursor Cell Lymphoblastic Leukemia-Lymphoma

10/14

11/15

NCT01403415: Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

	ASCO 2015
	May 2015 - May 2015: ASCO 2015

Completed

US, Canada

Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Laboratory Biomarker Analysis, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Mitoxantrone Hydrochloride, CL 232315, DHAD, DHAQ, Dihydroxyanthracenedione Dihydrochloride, Mitoxantrone Dihydrochloride, Mitoxantroni Hydrochloridum, Mitozantrone Hydrochloride, Mitroxone, Neotalem, Novantrone, Onkotrone, Pralifan, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Pharmacological Study, Temsirolimus, CCI-779, CCI-779 Rapamycin Analog, Cell Cycle Inhibitor 779, Rapamycin Analog, Rapamycin Analog CCI-779, Torisel, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate

National Cancer Institute (NCI)

Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma

05/15

NCT01078974: Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Terminated

pomalidomide, CC-4047, Pomalyst, dexamethasone, Decadron, rituximab, Rituxan

Steven P. Treon, MD, PhD, Celgene Corporation

Waldenstrom's Macroglobulinemia

09/15

03/16

NCT01421173: Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Completed

Vorinostat, SAHA, Suberoylanilide Hydroxamic Acid, MSK-390, Zolinza, Gemcitabine, Gemcitabine Hydrochloride, Gemzar, Busulfan, Busulfex, Myleran, Melphalan, Alkeran, Stem Cell Infusion, Rituximab, Rituxan, G-CSF, Filgrastim, NeupogenTM, Palifermin, Kepivance, Dexamethasone acetate, Decadron

M.D. Anderson Cancer Center

Lymphoma

09/15

NCT01887587: Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia

Terminated

MLN9708, Ixazomib, Vincristine, Oncovin, Doxorubicin, Doxil, hydroxydaunorubicin, Dexamethasone, Decadron, Dexasone, Solurex, Baycadron

Ehab L Atallah

Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia

02/16

NCT01900509: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Completed

Bendamustine, Treanda(R), Bendamustine hydrochloride, Clofarabine, Clolar(TM), Clofarex, Etoposide, VP-16, Vepesid(R), Etoposide phosphate, Etopophos(R), Dexamethasone, Decadron(R)

St. Jude Children's Research Hospital, Teva Pharmaceuticals USA

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Acute Leukemia

05/16

NCT01722305: Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Completed

Mayo Clinic, National Cancer Institute (NCI)

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Central Nervous System Lymphoma, Intraocular Lymphoma, Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System, Recurrent Adult Diffuse Large Cell Lymphoma, Retinal Lymphoma

06/16

07/19

NCT01926665: Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)

Completed

Carfilzomib, Dexamethasone, Decadron

M.D. Anderson Cancer Center, Amgen

Lymphoma

09/17

NCT02293109: Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma

Completed

carfilzomib, Kyprolis, PR-171, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, doxorubicin hydrochloride, ADM, ADR, Adria, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, leucovorin calcium, CF, CFR, LV, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, rituximab, IDEC-C2B8, IDEC-C2B8 monoclonal antibody, Mabthera, MOAB IDEC-C2B8, Rituxan, laboratory biomarker analysis

Mehrdad Abedi, MD, Amgen

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia

12/17

01/18

NCT01363817: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Completed

Europe, US

BMS-906024, Notch inhibitor, Dexamethasone, Baycadron

Bristol-Myers Squibb

Lymphoblastic Leukemia, Acute T-cell, Precursor T-Cell Lymphoblastic Lymphoma

02/18

NCT02181218: Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Completed

Romidepsin, Istodax®, Gemcitabine, GEMZAR®, Oxaliplatin, Eloxatin TM, Dexamethasone, Decadron®, Dexamethasone Intensol®, Dexpak® Taperpak®, Pegfilgrastim, Neulasta®

Washington University School of Medicine, Celgene

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse

03/19

06/20

NCT02532192: A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Withdrawn

Belinostat, Rituximab, Rituxan, Cisplatin, Platinol-AQ, Platinol, CDDP, Cytarabine, Ara-C, Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, Dexamethasone, Decadron, Ciprofloxacin, Ciprofloxacin hydrochloride, Cipro, Fluconazole, Diflucan

M.D. Anderson Cancer Center, Spectrum Pharmaceuticals, Inc

Lymphoma

12/19

NCT03349281: Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Completed

Pevonedistat, TAK-924, MLN4924, Vincristine, Oncovin, VCR, LCR, Dexamethasone, Decadron, Hexadrol, Dexone, Dexameth, PEG-asparaginase, Oncaspar, Pegaspargase, Polyethylene Glycol Conjugated L-asparaginase-H, Doxorubicin, Adriamycin, Cytarabine, ARA-C, Methotrexate, MTX, Amethopterin, Hydrocortisone, Cortisol

Julio Barredo, MD, Takeda

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia

08/21

10/22

NCT04156828: Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Terminated

Copanlisib, 1032568-63-0, BAY 80-6946, PI3K Inhibitor BAY 80-6946, Gemcitabine, dFdCyd, Difluorodeoxycytidine, 1-(2-Oxo-4-amino-1, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Nealorin, Novoplatinum, Paraplatin, Paraplatine, Platinwas, Ribocarbo, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin Depot, Auricularum, Auxiloson, Baycadron, Baycuten, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone, Deltafluorene, Desameton, Dexa-Mamallet, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Rituximab, 174722-31-7, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, MabThera, Monoclonal Antibody IDEC-C2B8, Rituxan, Rituximab ABBS, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, rituximab-abbs, RTXM83, Truxima, Pegfilgrastim, 208265-92-3, Filgrastim SD-01, filgrastim-SD/01, Fulphila, HSP-130, Jinyouli, Neulasta, Pegfilgrastim Biosimilar HSP-130, Pegfilgrastim Biosimilar Pegcyte, Pegfilgrastim-jmdb, SD-01, SD-01 sustained duration G-CSF, Nyvepria, Pegfilgrastim Biosimilar Udenyca, Pegfilgrastim Biosimilar Ziextenzo, Udenyca, Ziextenzo

University of Washington, Bayer

Grade 3b Follicular Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma

04/22

06/23

NCT04681105: Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Active, not recruiting

Acetaminophen, APAP, Paracetamol, Tylenol, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Diphenhydramine, FAR 90X2, PM 255, Probedryl, Rigidyl, S51, Syntedril, Flotetuzumab, CD123 x CD3 DART Bi-Specific Antibody MGD006, CD123 x CD3 Dual Affinity Re-Targeting Bi-Specific Antibody MGD006, MGD006, RES234, S80880, Ibuprofen, (.+ -.)-p-Isobutylhydratropic acid, Advil, Motrin, p-Isobutylhydratropic acid, Ranitidine

City of Hope Medical Center, National Cancer Institute (NCI)

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hairy Cell Leukemia, Recurrent Hematologic Malignancy, Recurrent Hodgkin Lymphoma, Recurrent T Acute Lymphoblastic Leukemia, Refractory Acute Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Hairy Cell Leukemia, Refractory Hematologic Malignancy, Refractory Hodgkin Lymphoma, Refractory T Acute Lymphoblastic Leukemia, Systemic Mastocytosis

05/26

NCT05016947: Venetoclax Plus Inotuzumab for B-ALL

Recruiting

Venetoclax, Venclexta, Dexamethasone, Decadron, Dexasone, Diodex, Hexadrol, Maxidex, Inotuzumab Ozogamicin, Besponsa

Dana-Farber Cancer Institute, AbbVie

B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL

07/24

06/26

NCT05476770: Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Recruiting

US, RoW

Tagraxofusp, Elzonris, Fludarabine, Cytarabine, Cytosar, Dexamethasone, Decadron, Vincristine, Oncovin, Azacitidine, AZA, Vidaza, Methotrexate, MTX, Amethopterin, Cytarabine IT, Hydrocortisone

Therapeutic Advances in Childhood Leukemia Consortium

Hematologic Malignancy, AML, ALL, BPDCN, MDS, Lymphoblastic Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell, Hodgkin Lymphoma, Mixed Phenotype Acute Leukemia, Acute Undifferentiated Leukemia

11/25

11/27



	Diseases Companies Products Productz Mechanisms of Action Sites